Silexion Therapeutics Corp (SLXN) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan Silexion Therapeutics Corp. (SLXN)

Silexion Therapeutics Corp is integrating ESG principles into the development of RNA-based drugs for gastric cancer while strictly adhering to biosafety standards. The trend of quarterly earnings per share growth reflects the asset's dynamics, where the 52.50 level represents the current value. Silexion Therapeutics Corp is cultivating its image as an expert in KRAS mutation suppression, building an innovative R&D pipeline to combat solid tumors ahead of the launch of new clinical phases.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Silexion Therapeutics (SLXN): kanggo periode 17.08.2024 - 18.11.2026

Rincian analitis perusahaan Silexion Therapeutics Corp

Analisis fundamental perusahaan:Silexion Therapeutics Corp., SLXN
Produk asil prodhuksi Silexion Therapeutics Corp

Silexion Therapeutics Corp (SLXN) development of innovative RNA drugs against mutated cancer is reflected in the quarterly growth dynamics of earnings per share, which captures the percentage change in net income per common share relative to the same period last year. This indicator measures the efficiency of capitalizing on clinical successes and the interest of pharma behemoths in an acquisition, allowing investors to differentiate real financial progress from speculative expectations.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma, Inc.|CHRS: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CRDF|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BeyondSpring Inc. BYSI|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kazia (KZIA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nucana.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc